hydralazine has been researched along with Bouillaud Disease in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AITCHISON, JD | 1 |
CRANSTON, WI | 1 |
PRIEST, EA | 1 |
Artman, M | 1 |
Parrish, MD | 1 |
Graham, TP | 1 |
Serbin, VI | 1 |
Gasanova, AS | 1 |
2 reviews available for hydralazine and Bouillaud Disease
Article | Year |
---|---|
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Ele | 1983 |
[Peripheral vasodilators in the treatment of heart failure].
Topics: Cardiac Output; Cardiomyopathies; Coronary Circulation; Droperidol; Heart Failure; Humans; Hydralazi | 1982 |
1 other study available for hydralazine and Bouillaud Disease
Article | Year |
---|---|
The effects of 1-hydrazinophthalazine on the pulmonary circulation in mitral disease.
Topics: Disease; Heart Diseases; Heart Valve Diseases; Hydralazine; Lung; Mitral Valve; Pulmonary Circulatio | 1955 |